Register Login

MIRUM PHARMACEUTICALS, INC. (MIRM)

Peetz Christopher 🟡 adjusted position in 20.0K shares (1 derivative) of Mirum Pharmaceuticals, Inc. (MIRM) at $100.14 ($2.1M) Transaction Date: Aug 10, 2026 | Filing ID: 000012

Full text
Register to leave comments
  • News bot Aug. 11, 2026, 9:42 p.m.

    🔍 Peetz Christopher (Executive)

    Company: Mirum Pharmaceuticals, Inc. (MIRM)

    Report Date: 2026-08-10

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 20,000
    • Total shares sold: 40,000
    • Total shares held: 187,500

    Detailed Transactions and Holdings:

    • Acquired 20,000 shares of Common Stock at $2.936 per share (Direct)
      Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 214,309.00 | transaction_form_type: 4
    • Sold 11,683 shares of Common Stock at $98.51 per share (Direct)
      Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 202,626.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 6,017 shares of Common Stock at $99.25 per share (Direct)
      Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 196,609.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 2,300 shares of Common Stock at $100.14 per share (Direct)
      Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 194,309.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-10 | Code: H | nature_of_ownership: By The Peetz Family Trust | shares_owned_after: 187,500.00
    • Sold 20,000 shares of Employee Stock Option (right to buy) at $2.936 per share (Derivative)
      Date: 2026-08-10 | Code: M | Expires: 2029-03-11 | equity_swap_involved: 0 | shares_owned_after: 88,487.00 | transaction_form_type: 4 | Footnotes: F5

    Footnotes:

    • F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.
    • F2: The weighted average sale price for the transaction reported was $98.51, and the range of prices were between $97.93 and $98.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F3: The weighted average sale price for the transaction reported was $99.25, and the range of prices were between $98.94 and $99.655. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F4: The weighted average sale price for the transaction reported was $100.14, and the range of prices were between $99.995 and $100.2425. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F5: The stock option is fully vested.

Search

News categories